Cargando…
Malignancy in Systemic Lupus Erythematosus (SLE) Patients
BACKGROUND: Malignancies are among the leading causes of death in Systemic Lupus Erythematosus (SLE) patients with studies reporting a higher prevalence of malignancy in SLE patients compared to the general population. We wanted to determine the frequency of cancer in a cohort of SLE patients and id...
Autores principales: | Cader, Rizna Abdul, Yee, Amy Khoo Mei, Yassin, Azrul, Ahmad, Ismail, Haron, Siti Nurfatin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428534/ https://www.ncbi.nlm.nih.gov/pubmed/30583682 http://dx.doi.org/10.31557/APJCP.2018.19.12.3551 |
Ejemplares similares
-
Systemic lupus erythematosus with a non functioning pituitary macroadenoma
por: Nadira, Ummi, et al.
Publicado: (2012) -
An interesting case of systemic lupus erythematosus presenting with hypercalcemia: A diagnostic dilemma
por: Abdul Gafor, Abdul Halim, et al.
Publicado: (2013) -
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010) -
Pauci-immune Glomerulonephritis in Systemic Lupus Erythematosus (SLE)
por: Liebowitz, Jason, et al.
Publicado: (2018) -
Liver involvement in juvenile systemic lupus erythematosus (SLE)
por: Mariniello, Generosa, et al.
Publicado: (2011)